Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 41,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Most Popular Stories
- UnitedHealth reveals details of option back-dating settlement
- Another attempt to halt Horizon BCBS of NJ's switch to for-profit
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Reimbursement issues lead some doctors to stop vaccinating
- Just say no: More doctors and medical centers banning drug samples
- AHA survey: Negative profit margins for hospitals
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Healthcare on track to set record for mass layoffs
- Study: EMRs can cut paid malpractice settlements
- Just say no: More doctors and medical centers banning drug samples
Poll
Featured Jobs
-
Chief Privacy Officer, Americas Region
IMS Health Incorporated - Plymouth Meeting, PA -
California RN Cath Lab
StaffPointe, LLC - Modesto, CA -
CA Nursing Direct. Medical/Telemetry
StaffPointe, LLC - San Francisco , CA -
California Hospital Pharmacist
StaffPointe, LLC - Central Valley , CA -
Texas Manager of Respiratory Therapy
StaffPointe, LLC - Laredo , TX
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Dilantin news from FierceHealthcare
Most Popular Dilantin story
News
Studies show problems with four big-name drugs
April 29, 2008 — 6:59am ET
It looks like yet another set of popular drugs are facing allegations that they pose safety risks. Drugs named this week in unfavorable studies include Fosamax, which may create heart problems for... Read more...
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





